Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06627504 · ClinicalTrials.gov registry record · NA
Type 1 Diabetes REst for Metabolic Health
A NA study of Type 1 Diabetes (T1D) and Sleep Health, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06627504: Recruiting NA study of Type 1 Diabetes (T1D) and Sleep Health, sponsored by University of Colorado, Denver.
NCT06627504 is a NA study of Type 1 Diabetes (T1D) and Sleep Health that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 50 participants, below the 178-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06627504, a NA study of Type 1 Diabetes (T1D) and Sleep Health, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Research has shown a link between poor sleep health and late circadian timing with cardiometabolic health in adolescents with type 1 diabetes (T1D). Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in T1D, which begins as early as adolescence, and current therapies are limited. Therefore, this study plans to investigate whether cardiometabolic health can be improved with increased sleep duration and advanced circadian timing in adolescents with T1D with habitually insufficient sleep. To answer this question, investigators will study adolescents with T1D who get \<7h sleep on school nights and measure changes in insulin sensitivity, glycemic control, and vascular function after one month of a sleep and circadian intervention (1+ hour longer time in bed each night plus evening melatonin and morning light therapy) compared to one month of typical sleep (usual school schedule).
Primary Outcome
Steady-state glucose infusion rate (M) normalized to free fat mass (FFM) and to steady-state insulin (M/I, \[mg/kg FFM/min\]/insulin) measured with hyperinsulinemic euglycemic clamp
Conditions Studied
Interventions
- BEHAVIORAL Sleep Health and Circadian Timing Intervention
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-12 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
What NCT06627504 shows while recruiting
NCT06627504 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 178-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (72% lower).
The record links to 2 conditions, with Type 1 Diabetes (T1D) appearing as the primary indexed condition, and to 1 intervention - of which Sleep Health and Circadian Timing Intervention is the first listed.
NCT06627504 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06627504 about?
NCT06627504 is a clinical study titled "Type 1 Diabetes REst for Metabolic Health". Research has shown a link between poor sleep health and late circadian timing with cardiometabolic health in adolescents with type 1 diabetes (T1D). Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in T1D, which begins as early as adolescence, and current therapies are li...
What is the current status of trial NCT06627504?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-08-12. Estimated completion is 2029-08-31.
What conditions does trial NCT06627504 study?
This clinical trial studies the following conditions: Type 1 Diabetes (T1D), Sleep Health.
What interventions are being tested in trial NCT06627504?
The interventions under investigation include: Sleep Health and Circadian Timing Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06627504?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06627504 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes (T1D)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06627504's enrollment target sits among peer trials
50 9th of 17 higher than 9 of 17 other Type 1 Diabetes (T1D) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes (T1D) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Circadian Mechanisms, Glucose, and CV Risks in T1D
RECRUITING · NA
-
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
RECRUITING · NA
-
Automated Insulin for Management of Intrapartum Glycemia
RECRUITING · NA
-
Digital Mindfulness for Young Adults With Type 1 Diabetes
RECRUITING · NA
-
Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI